HUE061201T2 - Káliumhidroxid alkalmazása aktinikus keratózis kezelésében - Google Patents

Káliumhidroxid alkalmazása aktinikus keratózis kezelésében

Info

Publication number
HUE061201T2
HUE061201T2 HUE15739539A HUE15739539A HUE061201T2 HU E061201 T2 HUE061201 T2 HU E061201T2 HU E15739539 A HUE15739539 A HU E15739539A HU E15739539 A HUE15739539 A HU E15739539A HU E061201 T2 HUE061201 T2 HU E061201T2
Authority
HU
Hungary
Prior art keywords
treatment
potassium hydroxide
actinic keratosis
keratosis
actinic
Prior art date
Application number
HUE15739539A
Other languages
English (en)
Inventor
Thomas Wimmer
Bertil Wachall
Philip Zoeller
Alessandro Giunta
Original Assignee
Infectopharm Arzneimittel Und Consilium Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Infectopharm Arzneimittel Und Consilium Gmbh filed Critical Infectopharm Arzneimittel Und Consilium Gmbh
Publication of HUE061201T2 publication Critical patent/HUE061201T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
HUE15739539A 2015-07-10 2015-07-10 Káliumhidroxid alkalmazása aktinikus keratózis kezelésében HUE061201T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2015/065840 WO2017008831A1 (en) 2015-07-10 2015-07-10 Use of potassium hydroxide in the treatment of actinic keratosis
EP15739539.3A EP3319637B1 (en) 2015-07-10 2015-07-10 Use of potassium hydroxide in the treatment of actinic keratosis

Publications (1)

Publication Number Publication Date
HUE061201T2 true HUE061201T2 (hu) 2023-05-28

Family

ID=53716451

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE15739539A HUE061201T2 (hu) 2015-07-10 2015-07-10 Káliumhidroxid alkalmazása aktinikus keratózis kezelésében

Country Status (19)

Country Link
US (1) US11045494B2 (hu)
EP (1) EP3319637B1 (hu)
JP (1) JP6659735B2 (hu)
AU (1) AU2015402192B2 (hu)
CA (1) CA2986295C (hu)
DK (1) DK3319637T3 (hu)
ES (1) ES2934131T3 (hu)
FI (1) FI3319637T3 (hu)
HR (1) HRP20221528T1 (hu)
HU (1) HUE061201T2 (hu)
IL (1) IL255291A0 (hu)
MX (1) MX2017014998A (hu)
NZ (1) NZ736342A (hu)
PL (1) PL3319637T3 (hu)
PT (1) PT3319637T (hu)
RU (1) RU2706234C2 (hu)
UA (1) UA122145C2 (hu)
WO (1) WO2017008831A1 (hu)
ZA (1) ZA201706946B (hu)

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5315404B2 (hu) * 1973-12-29 1978-05-24
JPS5315404A (en) * 1976-07-29 1978-02-13 Hiromitsu Shimada Dermal resolvent and planing agent
US5084263A (en) * 1989-07-24 1992-01-28 Mccoy/Defalco Electrochemics, Inc. Method of preparing inorganic polymeric water complexes and products so produced
RU2146919C1 (ru) 1999-10-05 2000-03-27 Щербань Владимир Петрович Средство для удаления бородавок
EP1237479A2 (en) 1999-10-06 2002-09-11 National Research Council of Canada Non-invasive screening of skin diseases by visible/near-infrared spectroscopy
IE20000110A1 (en) * 2000-02-07 2001-08-22 Loctite R & D Ltd Applicator, Applicator Cap and a Container Having an Applicator Cap
RU2201236C2 (ru) 2001-06-01 2003-03-27 Щербань Владимир Петрович Средство для удаления доброкачественных новообразований на коже
EP1423126B1 (en) 2001-08-14 2007-08-29 Valderm APS Treatment of hyperproliferative conditions of body surfaces
US20030059450A1 (en) 2001-09-24 2003-03-27 Maibach Howard I. Method and topical formulation for treating skin conditions associated with aging
UA81222C2 (en) 2003-10-20 2007-12-25 Preparation for the removal of nonmalignant neoplasms on skin
WO2005065668A2 (en) * 2003-12-29 2005-07-21 Qlt Usa, Inc. Topical compositions comprising halo-deoxyadenosines for treatment of skin disorders
PL2051691T3 (pl) 2006-10-13 2010-10-29 Evonik Degussa Gmbh Kompozycja do leczenia skóry
CA2672956C (en) 2006-10-26 2015-02-10 Amgen Inc. Calcium receptor modulating agents
EP2143421A1 (en) 2008-07-07 2010-01-13 Almirall Hermal GmbH Topical composition for the treatment of actinic keratosis
CN101991599A (zh) 2009-08-24 2011-03-30 谭国梁 可使病变组织及病原体溶解消除的药物
US8652534B2 (en) 2009-10-14 2014-02-18 Berry Pharmaceuticals, LLC Compositions and methods for treatment of mammalian skin
UA56321U (ru) 2010-06-17 2011-01-10 Сергей Владимирович Селихов Средство гигиеническое для удаления новообразований кожных тканей
US20140357726A1 (en) 2011-11-30 2014-12-04 Merz Pharma Gmbh & Co. Kgaa Use of pegylated alcohols for the treatment of actinic keratosis
NZ606177A (en) * 2012-01-30 2014-03-28 Dolorgiet Gmbh & Co Kg Compositions for the treatment of actinic keratosis
US9693574B2 (en) 2013-08-08 2017-07-04 Virun, Inc. Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch
EP2860130B1 (de) * 2013-10-11 2016-01-06 Infectopharm Arzneimittel und Consilium GmbH Sicherheitsflasche

Also Published As

Publication number Publication date
PT3319637T (pt) 2022-12-27
ZA201706946B (en) 2019-02-27
FI3319637T3 (fi) 2023-02-22
AU2015402192A1 (en) 2017-11-02
AU2015402192B2 (en) 2021-06-10
US11045494B2 (en) 2021-06-29
MX2017014998A (es) 2018-03-23
NZ736342A (en) 2020-05-29
PL3319637T3 (pl) 2023-03-20
ES2934131T3 (es) 2023-02-17
CA2986295C (en) 2023-01-03
CA2986295A1 (en) 2017-01-19
US20180185409A1 (en) 2018-07-05
EP3319637B1 (en) 2022-11-09
IL255291A0 (en) 2017-12-31
WO2017008831A1 (en) 2017-01-19
RU2017138375A3 (hu) 2019-05-06
HRP20221528T1 (hr) 2023-02-17
DK3319637T3 (da) 2023-02-06
EP3319637A1 (en) 2018-05-16
JP6659735B2 (ja) 2020-03-04
UA122145C2 (uk) 2020-09-25
RU2017138375A (ru) 2019-05-06
RU2706234C2 (ru) 2019-11-15
JP2018519276A (ja) 2018-07-19

Similar Documents

Publication Publication Date Title
IL281793A (en) Use of cannabinoids in the treatment of epilepsy
IL283086A (en) Use of cannabidiol in the treatment of multiple sclerosis complex
HK1253580A1 (zh) 大麻二酚在治療癲癇中的用途
IL271631B (en) Deuterium compounds and their use
PT3334422T (pt) Utilização de ácido canabidiólico no tratamento de epilepsia
PL3157511T3 (pl) Zastosowanie kannabinoidów w leczeniu padaczki
GB2539129B (en) Salvaging hardware transactions
IL251905A0 (en) Epilimod for use in the treatment of kidney cancer
HK1245658A1 (zh) 可用於治療ibd患者的營養組合物
IL248767B (en) Trimethoxyphenyl-benzaimidazole compounds for cancer treatment
PL3277280T3 (pl) Izomiosmina do zastosowania w leczeniu chorób autoimmunologicznych
PT3160464T (pt) 6-hidroxibuspirona para uso no tratamento de transtornos do movimento
GB2553527B (en) Headgear suitable for use in hydrotherapy
LT3200783T (lt) Eritromelalgijos gydymas
IL255291A0 (en) Using potassium hydroxide to treat actinic keratosis
IL247207B (en) Use of pericalcitol in the treatment of inflammatory anemia
GB201511772D0 (en) Improvements in the treatment of ash
EP3109204A4 (en) Water treatment unit
GB201416686D0 (en) Cine 8